SCHEMBL3965026

SCHEMBL3965026

O=C1c2ccccc2OC(Cl)C1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.47
MAOB P27338 3/20 0.47
ADORA3 P0DMS8 2/20 0.47
KDM4E B2RXH2 1/20 0.47
AR P10275 1/20 0.47
HSD17B10 Q99714 1/20 0.47
RET P07949 1/20 0.45
KDR P35968 1/20 0.45
CYP3A4 P08684 2/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
HTR2B P41595 1/20 0.41
ALDH1A1 P00352 1/20 0.40
S100A4 P26447 2/20 0.39
POLB P06746 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16376660 0.82 ESR1 (0.55) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL18885280 0.79 CYP19A1 (0.47) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL21371327 0.79 CYP19A1 (0.47) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL29963529 0.79 RET (0.49) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL501137 0.79 RET (0.49) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL11741033 0.78 S100A4 (0.56) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL14926094 0.74 ESR1 (0.51) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL11254869 0.74 CYP19A1 (0.48) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL5889384 0.74 ALDH1A1 (0.53) CYP19A1MAOBADORA3KDM4EAR
SCHEMBL10516436 0.74 RET (0.50) CYP19A1MAOBADORA3KDM4EAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009049214-A2 INHIBITION AND TREATMENT OF PROSTATE CANCER METASTASIS NORTHWESTERN UNIVERSITY (US) 2009-04-16 WO disclosed